nbryo
Revolutionizing
Global Beef and Dairy Production
7 YEARS to 7 DAYS
Nbryo is a cutting-edge biotechnology venture focused on transforming global beef and dairy supply chains through next-generation breeding technologies. With a mission to significantly increase productivity while reducing methane emissions, Nbryo's platform represents a breakthrough in the way livestock genetics are advanced, scaled, and applied across global agricultural systems.
Overview
Founded in 2021 by pharmaceutical entrepreneur Euan Murdoch and genetics innovator Nick Cameron, Nbryo builds on over 15 years of pioneering success in assisted reproduction technologies, developed for Australia's leading producers.
The company is backed by experienced shareholders and notable venture capital investors within the agtech and agrifood sectors. Its leadership includes Chair Gerard Davis, founder of Catapult Genetics (acquired by Pfizer Inc.), bringing decades of expertise in livestock molecular genetics to guide Nbryo's growth and commercial trajectory.
Milestones and tech development
15+ YEARS
Research into embryo transfer by Noodooinbah.
2021
Nbyro created. Major grant funding. First patent filed on twinning process.
2022
Second patent filed. First twinned calves born.
2023
Proprietary embryo media developed and trialled.
2024
Transfer device prototype design and developed. Third patent filed.
2025
Pilots with commercial partners.
The opportunity
The challenges faced by the world include:
Food security
By 2050 the Food and Agriculture Organization estimates that we will need to produce 60% more food to feed an expected 9.7B people.
Environmental
1.5 bn cattle worldwide account for 9-10% of all green house gases.
Geo-political stability
Livestock supports 40% of global agricultural value with 1.3 billion people relying on livestock for their livelihoods.
Outdated breeding techniques
Natural mating and artificial insemination are slow to make genetic changes and are difficult to scale.
Limited access to technology
IVF is very expensive and technically complex, currently limited to elite livestock producers.
Production loss
There is significant wastage in the system.
leadership
World Class Leadership
Meet the team leading the success of Nbryo.
Euan Murdoch
Founder
Paul Niven
Chief Executive Officer
Nick Cameron
Co-Founder
Jim Hunter
Chief Financial Officer
Lewis Frost
Head of Growth and Marketing
Sophia Edwards
Head of Platform
Learn more
To learn more about Nbryo and their recent updates, visit their website below.
Nbryo Supplementary Information Memorandum
This document provides additional or updated information relating to the original Nbryo Information Memorandum and should be read in conjunction with it. It includes important amendments, clarifications, or disclosures relevant to the investment offering.
Opportunity-Plus Investment Fund
Connecting institutional, accredited, and high-net-worth investors with carefully vetted opportunities across pharma and agribiotech.
Contact
© 2026 Opportunity-Plus Investment Fund (OPIF). All rights reserved.